Autopsy report · NCT01720056

Verapamil vs Steroid to Prevent Keloid Recurrence

“Objective of study achieved after interim analysis.”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 5 months before it stopped.
• 14 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

The University of Western Australia

Sponsor type

University, hospital or other

Conditions

Keloid Scars

Interventions

Verapamil; Kenalog 10

Participants

14

Sites

1

Countries

Australia

Trials that died the same way

• Linifanib in Treating Patients With Advanced, Refractory Colorectal Cancer
  “Interim analysis determined the study did not meet criteria to proceed” (82% match in meaning)
• Alprostadil in Maculopathy Study (AIMS)
  “Interim Analysis: Optimization of study design required.” (81% match in meaning)
• Study of Pemetrexed for Second-Line Pancreas Cancer
  “At interim analysis the study did not meet the response criteria to continue” (80% match in meaning)
• Impact of an Immune Modulator Dimethyl Fumarate on Acute Ischemic Stroke
  “The interim analysis of another associated study is not very effective” (79% match in meaning)
• Moxonidine in Patients Undergoing Vascular Surgery
  “Study was stopped after pre-definied interim analysis because of no effects” (77% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.